Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by an expanded glutamine tract in human Ataxin-1 (hAtx-1). The expansion stabilizes hAtx-1, leading to its accumulation. To understand how stabilized hAtx-1 induces selective neuronal degeneration, we studied Drosophila Atx-1 (dAtx-1), which has a conserved AXH domain but lacks a polyglutamine tract. Overexpression of hAtx-1 in fruit flies produces phenotypes similar to those of dAtx-1 but different from the polyglutamine peptide alone. We show that the Drosophila and mammalian transcription factors Senseless/Gfi-1 interact with Atx-1's AXH domain. In flies, overexpression of Atx-1 inhibits sensory-organ development by decreasing Senseless protein. Similarly, overexpression of wildtype and glutamine-expanded hAtx-1 reduces Gfi-1 levels in Purkinje cells. Deletion of the AXH domain abolishes the effects of glutamine-expanded hAtx-1 on Senseless/Gfi-1. Interestingly, loss of Gfi-1 mimics SCA1 phenotypes in Purkinje cells. These results indicate that the Atx-1/Gfi-1 interaction contributes to the selective Purkinje cell degeneration in SCA1.
teractions might contribute to the disease process and how they might cause toxicity in only a subset of neurons in SCA1 is not fully understood.
To gain insight into how Atx-1's function contributes to SCA1 pathogenesis, we studied the Drosophila Atx-1 homolog (dAtx-1), which lacks a polyQ tract, and compared its in vivo effects and interactions to those of the human protein. Here we show that overexpression of hAtx-1 induces phenotypes similar to those of dAtx-1 overexpression but distinct from those observed upon overexpression of polyQ chains in flies. Furthermore, we identify the Drosophila zinc-finger transcription factor Senseless (Sens) and its mammalian homolog growth factor independence-1 (Gfi-1) as physical and genetic interactors of Drosophila and mammalian Atx-1, respectively. We propose that the Sens/Gfi-1 interaction provides a mechanism for SCA1 pathogenesis and the selective vulnerability of PCs in this disease. Figure 1A) . Phylogenetic-tree analysis indicates that dAtx-1 shows higher sequence homology with hAtx-1 and its paralog Atx-1-like (H.-K.C. and H.Y.Z., unpublished data) than with HBP1 or any other human protein (data not shown). There is also a small protein corresponding to the AXH domain in C. elegans, suggesting that this domain serves as an independent functional unit ( Figure 1A) .
Results

dAtx-1 and hAtx-1 Induce Similar Phenotypes When Overexpressed in Flies
To test the function of the AXH domain, we overexpressed dAtx-1 in flies using the GAL4/UAS system (Brand and Perrimon, 1993) and compared its effects to those of hAtx-1. Overexpression of dAtx-1 by Rhodopsin1(Rh1)-GAL4, which drives expression in the differentiated R1-R6 photoreceptor cells (Mollereau et Figures 1B-1D) . Overexpression of dAtx-1 using the GMR-GAL4 driver also induces eye abnormalities. The external structures of the eyes that overexpress dAtx-1 show disorganized ommatidia and loss of interommatidial bristles ( Figure 1F ), and these eyes exhibit loss of rhabdomeres and tissue integrity ( Figure 1J ). In both cases, dAtx-1 phenotypes are similar to but milder than hAtx-1. We also found that dAtx-1 and hAtx-1 induce similar phenotypes in other tissues. Although the GMR-GAL4 driver is mainly eye specific (Freeman, 1996), it also induces a broad low-level expression in the wing during the early pupal stage (Figure 1L) . Interestingly, expression of dAtx-1 and hAtx-1[82Q] using GMR-GAL4 generates extra wing-vein tissue ( Figures 1N and 1O ). Similar to the eye phenotypes, dAtx-1 overexpression causes a milder phenotype.
To examine the wing phenotypes induced by Atx-1, we overexpressed dAtx-1 in the wing pouch using C5-GAL4 (Yeh et al., 1995) and in the wing margin using C96-GAL4 (Gustafson and Boulianne, 1996). Overexpression of dAtx-1 using the wing-pouch driver at 27°C causes several vein abnormalities ( Figure 1R ). Overexpression of hAtx-1[82Q] at 27°C has a more severe phenotype and causes an atrophic wing ( Figure 1S ). When flies overexpressing hAtx-1 are incubated at 23°C to lower the level of hAtx-1[82Q] expression, we observe a phenotype similar to that of dAtx-1 (inset in Figure  1S Figure 1T ). Furthermore, overexpression of 127Q with the wing-margin driver does not cause patterning defects as observed with Atx-1 overexpression ( Figure 1X ). Because hAtx-1 induces phenotypes similar to dAtx-1 and since these phenotypes are not induced by the polyQ tract, we conclude that the polyQ tract is not necessary to generate the gain-of-function phenotype of Atx-1 in flies.
Drosophila and Mammalian Ataxin-1 Physically Interact with Sens and Gfi-1 Based on the similar phenotypes of dAtx-1 and hAtx-1 in Drosophila (Figure 1) , we hypothesized that some of the aberrant signaling may be conserved between dAtx-1 and hAtx-1. We focused on the bristle phenotypes. Bristles are mechanosensory organs of the peripheral nervous system (PNS) that develop from epidermal cells through the coordinated activities of proneural proteins and Sens, a zinc-finger transcription factor required for the generation of sensory organs in gesting that the AXH domain mediates the direct interaction between the two proteins. To find the reciprocal domain of Sens/Gfi-1 that binds Atx-1, we tested deletion constructs for their ability to bind dAtx-1 or hAtx-1. As shown in Figures S1A and S1B in the Supplemental Data available with this article online, the amino-terminal regions, not the zinc-finger domain of Sens or Gfi-1, are sufficient for the interaction with dAtx-1 or hAtx-1, respectively. Lastly, to confirm the interaction in vivo, we performed CoIP assays using mouse brain extracts. The anti-Atx-1 antibody coimmunoprecipitates Gfi-1 from brain extracts of wt mice but not from extracts of atx-1 null mice (Matilla et al., 1998) ( Figure 2F ), indicating that the two proteins interact in vivo. In summary, our data indicate that dAtx-1 and hAtx-1, via the AXH domain, can bind to Sens and Gfi-1, respectively. Figures 3C and 3D) . In mice, Gfi-1 is expressed in many areas that give rise to neuronal cells during embryonic development (Wallis et al., 2003) . However, our data show that, in the adult cerebellum, Gfi-1 expression is mainly confined to PCs, where Atx-1 is most abundant (Figures 3E-3G ) (Banfi et al., 1996).
Sens and
Ataxin-1 Inhibits Sens Function during SOP Formation
To address the relevance of the biochemical interactions between Atx-1 and Sens, we examined the functional relationship between these proteins in vivo. Sens 
Atx-1 Decreases the Level of Sens Protein in a Cell-Autonomous Manner
To explore the mechanism by which Atx-1 suppresses Sens function, we evaluated the levels of Sens protein in wing imaginal discs, where it is expressed in the SOPs ( Figure 5A) (Nolo et al., 2000) . Using the Scabrous driver, we found that overexpression of either fly or human Atx-1 decreases the level of endogenous Sens protein (Figures 5A-5C ). Consistent with the bristle phenotypes, overexpression of hAtx-1[82Q] has a more severe effect on Sens levels than dAtx-1 (Figures 5B  and 5C ). Overexpression of Atx-1 using GMR-GAL4 also suppresses Sens protein levels in the R8 photoreceptor cells (data not shown), where Sen is expressed (Frankfort et al., 2001) .
We then assessed whether Atx-1 exerts its activity on Sens in a cell-autonomous manner. In the wing margin, Sens is expressed in several rows of cells flanking Figures 5J and 5L , overexpression of hAtx-1[82Q] using the dpp-GAL4 driver causes a loss of Sens protein, but the cells flanking the hAtx-1 overexpression domain are not affected (Figures 5I-5L) . Furthermore, Wingless expression in the wing margin is not decreased in the cells in which hAtx-1 is overexpressed ( Figure 5K and arrow in Figure 5L ). These data demonstrate that the effects of Atx-1 on Sens are cell autonomous. Overexpression of dAtx-1 using the dpp-GAL4 driver also decreases the level of Sens (data not shown). Furthermore, the effect of hAtx-1[82Q] on Sens levels is not merely due to the expanded polyQ tract, as overexpression of 127Q or hAtx-1[82Q] lacking AXH domain has no significant effects on Sens levels (Figures 5N-5Q ).
E and F) The effect of Sens overcomes those of dAtx-1 (E) and hAtx-1[82Q] (F). (G) Quantification of the number of macrochaetae shown in panels (A)-(F). Error bars indicate 95% confidence interval. (H-K) Transcription assay in S2 cells
the dorsoventral margin, where the Wingless gradient is at its peak (Figures 5E-5G). Sens expression in these cells, which will give rise to wing-margin SOPs, is thought to be dependent on Wingless (Parker et al., 2002). As shown in
To determine whether the loss of Sens in the Atx-1 overexpression domain is due to cell death or decreased Sens transcription, we examined the level of sens RNA in the wing margin with or without Atx-1 overexpression. In situ hybridization for sens showed that Atx-1 overexpression does not affect sens mRNA levels (Figure 5M) , suggesting an effect at the protein level and ruling out cell death as a cause. The direct physical interaction between Atx-1 and Sens raises the possibility that Atx-1 might cause the Sens protein to become unstable. 
Gfi-1 Expression Is Decreased in SCA1-Transgenic
Overexpression of hAtx-1[82Q] using the dpp-GAL4 driver decreases Sens protein (arrow in [J] and [L]) but not Wingless protein (K and L) or sens mRNA levels (M). (N-Q) Overexpression of 127Q or hAtx-1[82Q] lacking AXH domain does not have significant effects on Sens expression. dpp-GAL4/+; UAS-HA-127Q/+ (N and O). dpp-GAL4/+; UAS-hAtx-1[82Q]AXH(-)/+ (P and Q). Staining is with anti-HA (N), anti-hAtx-1 (P), and anti-Sens (O and Q).
These mice develop ataxia after 5 weeks of age and show significant loss of PCs after 6 months (Burright et al., 1995; Clark et al., 1997). We observed a marked decrease in Gfi-1 protein levels in PCs of these mice compared to wt mice ( Figures 6B and 6E) . The decrease in Gfi-1 protein levels occurs at a time when there is no significant loss of PCs, as determined by calbindin staining (Figure 6D) . Lastly, to confirm that the effect of hAtx-1 on Gfi-1 is indeed mostly due to sequences other than the glutamine tract, we evaluated Gfi-1 levels in mice overexpressing wt hAtx-1[30Q]. These mice, when bred to homozygosity and aged, develop Purkinje cell degeneration. Here again, we find Gfi-1 levels to be decreased (Figures 6J-6L) , suggesting that the functional and physical interactions of Atx-1 and Sens/Gfi-1 are conserved between Drosophila and mice.
Atx-1 Destabilizes Gfi-1 by Enhancing Its Degradation via the Proteasome
To explore the mechanism by which Atx-1 reduces Gfi-1 levels, we examined the effect of Atx-1 on the degradation of Gfi-1. We used pulse-chase radiolabeling analysis to evaluate the stability of endogenous Gfi-1. About 72% of the labeled Gfi-1 remains in control cells after 2 hr. However, in cells which express dAtx-1 or hAtx-1[82Q], Gfi-1 is less stable (46% and 31% remaining, respectively). Gfi-1's stability is not affected in cells that expressed hAtx-1[82Q] lacking the AXH domain (78% remaining) (Figures 6M and 6N) . These data suggest that Atx-1 enhances the degradation of Gfi-1 upon interaction via its AXH domain.
To determine if Gfi-1's degradation is dependent on the proteasome, we examined the effect of proteasome inhibition on the stability of Gfi-1. Whereas mocktreated cells have no Gfi-1 immunofluorescence 72 hr after transient transfection of Gfi-1 expression vector, proteasome-inhibitor-treated cells accumulate Gfi-1 ( Figure S2D) . Moreover, accumulated Gfi-1 colocalizes with the 20S proteasome ( Figures S2D-S2F) , suggesting that Gfi-1 degradation is via the proteasome pathway. We next examined whether inhibiting the proteasome can interfere with the effect of Atx-1 on Gfi-1 stability. Treatment of cells with proteasome inhibitor leads to the accumulation of Gfi-1 in the hAtx-1[82Q] transfected cells, suggesting that hAtx-1 enhances Gfi-1 degradation via the proteasome pathway (Figure 6O) . Figure 7D) . However, at 6 months of age, Gfi-1 null mice display a loss of PCs ( Figure 7E ). In addition, most of the surviving PCs exhibit abnormal nuclear and cytoplasmic morphology (arrowheads in Figure 7F ) in the soma and aberrant and disorganized dendrites ( Figure 7F ). The axons of the PCs have focal swellings (arrow in Figure 7F) , similar to what has been reported in SCA1 patients (Zoghbi and Orr, 2001 ). The observation that loss of PCs appears several months postnatally argues against a developmental defect and indicates that Gfi-1 contributes to survival of PCs. In summary, the cerebellar pathology in Gfi-1 mutant mice strongly suggests that alterations in the level of Gfi-1 may account in part for the PC-specific phenotype of SCA1. 
Loss of Gfi-1 Leads to Purkinje Cell Degeneration
Loss of One Copy of
Discussion
The expanded glutamine tract is clearly the initiating event in the pathogenesis of polyQ neurodegenerative disorders. In SCA1 and related disorders, the length of the glutamine tract correlates inversely with the age of onset and directly with the severity of the phenotype. Overexpression of a polyQ peptide in cell-culture, invertebrate, and mouse models is quite toxic and causes progressive dysfunction and cell death. However, there are several pieces of data that argue that the expanded glutamine tract is not the sole factor that induces pathology and determines disease severity. For example, several genetic studies support the idea that sequences outside of the glutamine tract are critical for causing neurodegeneration phenotypes in SCA1. Because the AXH domain is the likely mediator of the effects of Atx-1 overexpression, the prediction would be that this domain might mediate the biochemical and genetic interactions that modulate or contribute to the SCA1 phenotypes. Indeed, our data on the genetic and biochemical interactions of fly and hAtx-1 proteins with Drosophila Sens and its mammalian homolog Gfi-1 strongly support this prediction. The finding that the AXH domain of dAtx-1/hAtx-1 is necessary and sufficient for physical interactions with Sens/Gfi-1 underscores the cross-species functional conservation of this domain and the potential role of Sens/Gfi-1 in mediating Atx-1-induced phenotypes. In support of Atx-1's specific effect on Sens, we find that (1) Atx-1 has direct effects on Sens protein (not RNA) levels through the AXH domain; (2) Atx-1 antagonizes the activity of Sens, not that of Ac or Da, in a transcription assay; and (3) Sens overexpression suppresses the Atx-1-induced bristle phenotypes in flies. Similarly, hAtx-1 and Gfi-1 also genetically interact in mice, as evidenced by the worsening of PC pathology in a background heterozygous for a Gfi-1 loss-of function allele. Moreover, hAtx-1 reduces Gfi-1 protein levels in the absence of cell loss. Exactly how Atx-1 promotes the degradation of Sens/ Gfi-1 is not known at this time, but our data suggest that Atx-1 enhances the proteasome-mediated degradation of Gfi-1. We propose that Atx-1 and Sens/Gfi-1 interactions alter the conformation, modification, or other protein interactions of Sens/Gfi-1, rendering them less stable.
Gfi-1 Is Necessary for the Survival of Purkinje Cells
Given the decline of Gfi-1 levels in PCs of SCA1-transgenic mice, a key question is whether this decrease contributes to SCA1 pathogenesis. Indeed, we find that loss of Gfi-1 phenocopies SCA1 and causes PC degeneration after several months of normal PC development. . Gfi-1 is the first protein to fulfill the criteria to be a mediator of the SCA1 pathogenesis: it interacts physically and genetically with Atx-1 (as do the fly orthologs), loss of Gfi-1 copies the SCA1 phenotype in PCs, and Gfi-1 and SCA1 show a dose-dependent interaction. The molecular mechanisms described in the current study underscore the importance of studying the wt function and interactors of proteins involved in neurodegenerative diseases.
Experimental Procedures
For details on GST pull-down assays, IP, Western blotting analysis, and yeast two-hybrid assays, see Supplemental Experimental Procedures. 
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